Form 4 for LUNG Pulmonx Corp
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +31.0K | 154.7K | +25% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $25.91 | -426 | 123.7K | -0.3% | -$11.0K |
| D | 2022-03-03 | 2022-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +68.7K | 68.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 31,000 | $0.00 | 154,702 | D | — | — | (F3) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022. |
| 2 | Common | Common Stock | 2022-03-01 | S | D | 426 | $25.91 | 123,702 | D | — | — | (F2) Includes 669 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2022. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-03-01 | A | A | 68,700 | $0.00 | 68,700 | D | $26.56 · — to 2032-02-29 | 68,700 Common Stock | (F4) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022. |